KENNABAMINE
Live / Applied — First extension granted (statement of use) (as of 26 Feb 2026)
What this means for you
Not registered yet, but its 02 Jun 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98025453
- Mark type
- Stylized text
- Filed
- 02 Jun 2023
- Published for opposition
- 01 Jul 2025
- Attorney of record
- Jeffrey J. Ellison
Goods and services
- Class 005 — Pharmaceuticals: Preparations for the treatment of anxiety and depression containing cannabis ingredients solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) content of not more than 0.3 percent on a dry weight basis, and not containing cannabidiol (CBD)
Owner
- Progressive Therapeutics, Inc., Orleans, MA, US
- Progressive Therapeutics, Inc., Orleans, MA, US
Prosecution history
- 27 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Feb 2026 — SOU EXTENSION 1 GRANTED
- 26 Feb 2026 — SOU EXTENSION 1 FILED
- 26 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 26 Aug 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 01 Jul 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 01 Jul 2025 — PUBLISHED FOR OPPOSITION
- 25 Jun 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 02 Jun 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 30 May 2025 — EXAMINER'S AMENDMENT ENTERED
- 30 May 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 30 May 2025 — EXAMINERS AMENDMENT E-MAILED
- 30 May 2025 — EXAMINERS AMENDMENT -WRITTEN
- 22 May 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 22 May 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE